PTC-028
| CAS No. | 1782970-28-8 | Cat. No. | BCP20909 |
| Name | PTC-028 | ||
| Synonyms | PTC 028;PTC028; | ||
| Formula | C19H12F5N5 | M. Wt | 405.332 |
| Description | PTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification. In vivo, orally administered PTC-028, as a single agent, exhibits significant antitumor activity comparable with the standard cisplatin/paclitaxel therapy in an orthotopic mouse model of ovarian cancer. | ||
| Pathways | Apoptosis Pathway Others Pathway Wnt/Stem Cell | ||
| Targets | Apoptosis Inducer Autophagy BMI1 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.